Asterand, a supplier of human tissue samples to the drug development industry, expects to report its first annual profit this month.
After a year tightening up operations on both sides of the Atlantic, a wide-ranging management shake-up and the replacement of two-thirds of its sales force, 2008 was when these changes started to pay off.
